Full Text
Budget Impact Of Adding Delayed-Release Dimethyl Fumarate To The Formulary For The Treatment Of Relapsing Forms Of Multiple Sclerosis

Abstract

Authors

J.A. Mauskopf M. Fay R. Iyer T. Livingston

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×